Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC (2018) Linge A, Schoetz U, Loeck S, Lohaus F, Von Neubeck C, Gudziol V, Nowak A, et al. Journal article Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis (2018) Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, Gruen A, et al. Journal article SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy (2018) De-Colle C, Menegakis A, Moennich D, Welz S, Boeke S, Sipos B, Fend F, et al. Journal article QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Conference contribution Quality assurance for interstitial brachytherapy using an EMT system integrated into an afterloader (2018) Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Measuring the systemic immune-modulating effects of radiation (2018) Frey B, Gaipl U Conference contribution Fractionated SBRT for adrenal metastasis: contributing to local tumor control with modest toxicity (2018) Knippen S, Burjakow K, Putz F, Knippen A, Achterberg N, Lettmaier S, Fietkau R Conference contribution Implementation of registration quality assurance (2018) Anderle K, Brandt T, Wölfelschneider J, Bert C, Graeff C Conference contribution Examination of the automatic fiducial marker detection on the Vero system (2018) Ziegler M, Brandt T, Lettmaier S, Fietkau R, Bert C Conference contribution